Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States of America.
USDA/ARS Children's Nutrition Research Center, 1100 Bates Avenue, Houston, TX 77030, United States of America.
Bone. 2024 Jan;178:116930. doi: 10.1016/j.bone.2023.116930. Epub 2023 Oct 14.
To investigate the skeletal phenotype of adolescent girls with premature ovarian insufficiency (POI).
Data are presented from two adolescent girls who participated in a clinical research protocol to evaluate axial bone mineral density (BMD) (via dual-energy x-ray absorptiometry, DXA) and appendicular bone density, microarchitecture, and strength (via high-resolution peripheral quantitative computed tomography, HRpQCT). Anthropometric data were also obtained, and pubertal staging was performed by a clinician.
Both cases presented with an undetectable estradiol concentration and an elevated follicle stimulating hormone (FSH), meeting the criteria for POI. Each also received alkylating agents as part of their chemotherapy and radiotherapy, but in different locations as one presented with stage IV neuroblastoma and the other, metastatic medulloblastoma. Both had a low BMD of the axial and appendicular skeleton, as well as microarchitectural changes of the latter. The low BMD Z-score (<-2.0) seen when interpreting their DXA measurements for chronological age improved when adjusted for short stature, but it was not normalized. Lastly, most variables obtained by HRpQCT were abnormal for each participant, indicating that appendicular bone structure and strength were compromised.
Chemotherapy and radiation affect growth, puberty, and bone accrual deleteriously. However, as these cases show, POI in an adolescent is not always classic primary ovarian insufficiency. Adolescents with brain cancer can present with signs of estrogen deficiency but may not be able to secrete FSH to the extent of elevation typically seen in long-term cancer survivors. Estrogen deficiency is almost universally present in either clinical setting and prompt recognition facilitates early provision of hormone replacement therapy that may then allow for a resumption of bone accrual as an adolescent approaches her peak bone mass.
研究青春期卵巢功能不全(POI)少女的骨骼表型。
呈现了两名参与评估轴向骨密度(通过双能 X 射线吸收法,DXA)和四肢骨密度、微结构和强度(通过高分辨率外周定量 CT,HRpQCT)的临床研究方案的青少年女孩的数据。还获得了人体测量学数据,并由临床医生进行了青春期分期。
两个病例均表现为雌二醇浓度不可检测,促卵泡激素(FSH)升高,符合 POI 的标准。每个病例还接受了烷化剂作为其化疗和放疗的一部分,但在不同的部位,一个患有 IV 期神经母细胞瘤,另一个患有转移性髓母细胞瘤。两者均具有轴向和四肢骨骼的低骨密度,以及后者的微结构变化。当根据其 DXA 测量的年龄进行解释时,她们的 BMD Z 分数(<-2.0)较低,但在调整为身材矮小后得到改善,但并未恢复正常。最后,HRpQCT 获得的大多数变量对每个参与者均异常,表明四肢骨骼结构和强度受损。
化疗和放疗对生长、青春期和骨积累产生有害影响。然而,正如这些病例所示,青春期的 POI 并不总是经典的原发性卵巢功能不全。患有脑癌的青少年可能会出现雌激素缺乏的迹象,但可能无法分泌 FSH,其升高程度不如长期癌症幸存者通常所见。在这两种临床情况下,雌激素缺乏几乎普遍存在,及时识别有助于早期提供激素替代治疗,从而允许青少年接近其峰值骨量时恢复骨积累。